Schedule 13G ownership disclosure
DICE THERAPEUTICS INC
Security class unavailable · CUSIP: 23345J104
Event date: 2022-10-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.0200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001567619-22-019426
- Form type
- SC 13G
- Filer
- DICE Therapeutics, Inc.
- CIK
- CIK 1645569
- Filed
- Nov 10, 2022
- Reporting period
- Oct 31, 2022
- Description
- Schedule 13G beneficial ownership